Razvan Sandu

Razvan Sandu is a results-driven Business Unit Director for Cardiometabolic Health with a robust background in sales and marketing across the pharmaceutical and banking sectors. They have held various leadership positions at Eli Lilly and Company, including Marketing Manager and Associate Director, and have worked with organizations such as Aspen Pharmacare and Mylan Laboratories. Razvan holds degrees in International Business and Risk Management from Bucharest University of Economic Studies, and has demonstrated a commitment to continuous learning and adaptability in dynamic environments. Currently, they are focused on pursuing a challenging position that aligns with their entrepreneurial mindset.